Saturday, October 3, 2026

Dollar Index Drops 10.8% as Global Currency Markets Realign

The U.S. Dollar Index fell 10.8% in early 2026, continuing a shift that saw the euro rise 14% in 2025. The British pound gained 7% in 2025 but dropped to €1.13 by November 2026, its weakest level against the euro since April 2023.

LM Salvado
LM Salvado

March 17, 2026

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
Dollar Index Drops 10.8% as Global Currency Markets Realign
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The U.S. Dollar Index dropped 10.8% in early 2026, extending a global currency realignment that began with the euro's 14% appreciation in 2025.1 The shift reflects changing expectations for central bank policies across major economies, with traders repositioning ahead of a Federal Reserve leadership transition in June 2026.

The British pound illustrates the volatility gripping major currencies. Sterling gained 7% against the dollar in 2025 but fell to €1.13 against the euro in November 2026—the lowest level since April 2023.2 Against the dollar, the pound traded near $1.30. "GBP is under pressure," said Simon Phillips, managing director at No1 Currency.2 Jordan Rochester at Mizuho Bank warned the pound could fall below $1.30.2

Dollar weakness typically emerges when markets anticipate Fed rate cuts or when other central banks offer more attractive yields. The euro's 2025 strength suggested investors expected European Central Bank policy to diverge from the Fed's path.

Emerging markets saw sharp swings. Turkey's lira weakened 17% as carry trades unwound—a pattern where investors exit high-yielding but riskier currencies. Switzerland's franc strengthened as a safe-haven asset during the turbulence.

The realignment creates winners and losers globally. European exporters face margin pressure from the stronger euro, while U.S. exporters gain competitiveness. Multinationals with unhedged currency exposure see earnings volatility spike.

Markets are pricing in uncertainty around the June 2026 Fed leadership transition. New leadership often signals policy shifts, particularly around interest rates, inflation targets, and quantitative tightening. The dollar's 10.8% decline reverses a strengthening trend from 2021 to 2024. Whether this marks a sustained bear market or temporary correction remains the key question for global forex markets.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 7, 2026
    Ray Dalio says America is facing a ‘debt death spiral’ — but you can protect your portfolio with these 3 assets
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com